A Study in Healthy Volunteers to Evaluate the Pharmacokinetic Food Effect and Cardiac Safety of CCX168

Condition:   Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Intervention:   Drug: CCX168 Sponsor:   Amgen Completed

Source: ClinicalTrials.gov - August 11, 2023 Category: Research Source Type: clinical trials